Schering-Plough

"CELEBRATION OF RESCUE" EVENT SPOTLIGHTS 360-DEGREE VIEW OF NORTH SHORE ANIMAL LEAGUE AMERICA'S LIFE-SAVING MISSION

Retrieved on: 
Saturday, November 18, 2023

NEW YORK, Nov. 17, 2023 /PRNewswire/ -- North Shore Animal League America, the world's largest no-kill animal rescue and adoption organization, hosted a "Celebration of Rescue" on Friday, November 17 at the exquisite TriBeCa 360o overlooking the twinkling lights of Lower Manhattan. This year's event drew attendees from all sectors of New York's animal-loving community and beyond, many of whom have adopted from North Shore Animal League America. Television personality and executive producer Brian Balthazar served as Host for the evening's festivities and North Shore Animal League America foster-parent, spokesperson, and Board Member Beth Stern was the event's Chairperson.

Key Points: 
  • This year's event drew attendees from all sectors of New York's animal-loving community and beyond, many of whom have adopted from North Shore Animal League America.
  • Television personality and executive producer Brian Balthazar served as Host for the evening's festivities and North Shore Animal League America foster-parent, spokesperson, and Board Member Beth Stern was the event's Chairperson.
  • Actors Lily Rabe and Edie Falco, longtime Animal League America supporters, provided voice overs for these moving segments.
  • To learn more about Celebration of Rescue, the Online Auction, and to donate, visit www.animalleague.org/celebrationofrescue
    Celebration of Rescue supports North Shore Animal League America's ever-expanding no-kill mission with all proceeds from the event dedicated to the ongoing no-kill mission to Rescue, Nurture, Adopt, and Educate.

Petco Love Distributes Two Millionth Free Pet Vaccine for Community Pets

Retrieved on: 
Thursday, November 16, 2023

SAN ANTONIO, Nov. 16, 2023 /PRNewswire/ -- Petco Love reaches its goal of distributing two million free pet vaccines for family pets through its Vaccinated and Loved campaign, saving pets lives by preventing the spread of deadly diseases and supporting families unable to afford necessary vaccines. The national nonprofit organization also commits to distributing an additional one million free pet vaccines, as part of its mission to make pet families healthier and increase access to veterinary care in communities across the country.

Key Points: 
  • Vaccinated and Loved marked its first significant milestone in September 2022, when Petco Love reached its one-millionth free pet vaccine distribution for family pets and committed to another one million free pet vaccines.
  • Now, Petco Love celebrates that two millionth free pet vaccine, distributed on Veteran's Day in San Antonio, Texas by Petco Love partner and nonprofit organization Spay Neuter Network at its free vaccine clinic.
  • A 20-year-old dog named Rowdy attending with his pet parent, a U.S. veteran, received the two millionth free pet vaccine!
  • Petco Love surveyed pet parents1 attending the free clinics to assess whether the initiative met its goal to reach pets most in need.

K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer

Retrieved on: 
Wednesday, November 15, 2023

CAMBRIDGE, Mass., Nov. 15, 2023 /PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor KTX-1001 for t(4;14) multiple myeloma, today announced that Benjamin Winograd, MD, PhD, has been appointed Chief Medical Officer to lead the Medical and Clinical teams. Dr. Winograd joins K36 with a wealth of experience and a remarkable track record of bringing innovative medicines for hematological and solid tumor disease treatments to patients.

Key Points: 
  • Additional industry veterans recruited to strengthen clinical, translational medicine and preclinical teams
    CAMBRIDGE, Mass., Nov. 15, 2023 /PRNewswire/ -- K36 Therapeutics, Inc .
  • ("K36"), a clinical-stage biotech company focused on developing its first-in-class MMSET inhibitor KTX-1001 for t(4;14) multiple myeloma, today announced that Benjamin Winograd, MD, PhD, has been appointed Chief Medical Officer to lead the Medical and Clinical teams.
  • "Recruiting a leader with Dr. Winograd's expertise, reputation and track record of advancing transformative therapies validates the potential opportunity that KTX-1001 will deliver," said Terry Connolly, PhD, President and Chief Executive Officer of K36.
  • Most recently, Dr. Winograd was the Chief Medical Officer at Lava Therapeutics B.V. Dr. Winograd brings over 30 years of industry experience to K36, and will lead clinical development, translational medicine, regulatory affairs, and medical affairs.

Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors

Retrieved on: 
Monday, November 6, 2023

"We are excited to welcome David to Adverum’s Board of Directors.

Key Points: 
  • "We are excited to welcome David to Adverum’s Board of Directors.
  • He brings an exceptional breadth of experience and a track record of success in pharmaceutical R&D and has launched multiple transformative products throughout his career, notably in ophthalmology," stated Patrick Machado, J.D., board chair of Adverum Biotechnologies.
  • “On behalf of the management team at Adverum, I’d like to extend a warm welcome to David,” added Laurent Fischer, M.D., president and chief executive officer of Adverum.
  • from the University of Manchester and his Ph.D. from the University of Wales.

Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors

Retrieved on: 
Wednesday, November 1, 2023

Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.

Key Points: 
  • Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.
  • Before that, he worked at Parke-Davis for 20 years, where he held positions of increasing responsibility in Chemistry and Drug Discovery and participated in collaboration oversight committees.
  • Early in his career, Dr. Bristol was a Principal Scientist at Schering-Plough, leading the gastrointestinal research program.
  • His drug discovery research has resulted in numerous publications, abstracts, and patents.

Volastra Therapeutics Appoints David Nicholson, Ph.D., to Board of Directors

Retrieved on: 
Monday, November 6, 2023

Volastra Therapeutics , a clinical-stage cancer biotechnology company, today announced the appointment of David Nicholson, Ph.D., as an independent member of its Board of Directors.

Key Points: 
  • Volastra Therapeutics , a clinical-stage cancer biotechnology company, today announced the appointment of David Nicholson, Ph.D., as an independent member of its Board of Directors.
  • Nicholson joins our board as the company is moving expeditiously through the clinic with two novel, differentiated oral KIF18A inhibitors, as well as a pipeline of synthetic lethal and immune-activating assets,” said Sandi Peterson, Chair of the Board.
  • Dr. Nicholson most recently served as EVP and Global Head of Research and Development at Allergan Pharmaceuticals.
  • Dr. Nicholson currently serves as the Chair of the Board of Exscientia, a world-leading artificial intelligence company focused on immunology, immuno-oncology and oncology.

Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors

Retrieved on: 
Wednesday, October 11, 2023

Dr. Mahony most recently served on the board of directors of Horizon Therapeutics from 2019 until its acquisition by Amgen in October 2023.

Key Points: 
  • Dr. Mahony most recently served on the board of directors of Horizon Therapeutics from 2019 until its acquisition by Amgen in October 2023.
  • “We are pleased to welcome Dr. Mahony, who has extensive leadership experience in global drug development and commercialization, to our board of directors,” said Herriot Tabuteau, MD, Chief Executive Officer of Axsome.
  • Dr. Mahony served on the board of directors of Vifor Pharma from 2019 until its acquisition by CSL Limited in 2022.
  • Dr. Mahony also serves on the board of directors of the Chordoma Foundation, a nonprofit dedicated to improving the lives of people affected by chordoma.

VMX 2024 KICKS OFF NEW YEAR AT PREEMINENT ANNUAL GLOBAL VETERINARY CONFERENCE

Retrieved on: 
Wednesday, October 4, 2023

ORLANDO, Fla., Oct. 4, 2023 /PRNewswire/ -- Following record-breaking attendance at the 2023 Veterinary Meeting & Expo (VMX), the North American Veterinary Community (NAVC) will host its 41st annual conference Jan. 13-17, 2024 in Orlando, FL at the Orange County Convention Center (OCCC) and everywhere virtually. As the veterinary industry's first conference of the year, VMX sets the direction for veterinary medicine annually and provides the veterinary industry's first continuing education, scientific sessions and hands-on workshops led by world-renowned veterinary leaders. More than 580 companies and organizations from around the world will showcase the latest in animal healthcare products, diagnostics and more in the award-winning Expo Hall. This year's "Show of Shows'' theme will introduce a World's Fair-like experience featuring food, entertainment, events and activities. It will also feature headlining entertainment including singer/songwriter Tyler Hubbard and Emmy-Award-winning actor and director Dan Levy.

Key Points: 
  • As the veterinary industry's first conference of the year, VMX sets the direction for veterinary medicine annually and provides the veterinary industry's first continuing education, scientific sessions and hands-on workshops led by world-renowned veterinary leaders.
  • As the veterinary industry's first conference of the year, VMX sets the direction for veterinary medicine annually.
  • "VMX is where the global veterinary industry gathers each year to learn the latest in veterinary medicine and where life-saving new products and innovations are introduced to the industry.
  • Veterinary and veterinary nurse/technician students, as always, may attend for free, and guest registration is also available.

Athersys Director Jane Wasman Appointed Board Chair

Retrieved on: 
Monday, October 2, 2023

Current Director Jane Wasman, JD, has been appointed Board Chair, effective September 28, 2023.

Key Points: 
  • Current Director Jane Wasman, JD, has been appointed Board Chair, effective September 28, 2023.
  • Ms. Wasman has served as a Director of the Company since November 2020, currently serving as Chair of Athersys’ Audit Committee and previously serving as Chair of its Nominations, Governance & Compliance Committee.
  • “We are delighted that Jane will now be chairing Athersys’ board.
  • “On behalf of the Athersys Board of Directors and the company’s employees, I am honored to assume the responsibilities of Board Chair and to help guide our various initiatives to drive shareholder value,” said Ms. Wasman.

NAVC and MentorVet Partner To Provide Veterinary Nurses/Technicians Access to New Approach to Mentorship

Retrieved on: 
Thursday, September 28, 2023

ORLANDO, Fla., Sept. 28, 2023 /PRNewswire/ -- The North American Veterinary Community (NAVC) announces its support of MentorVet Tech, a new program created by MentorVet that is redefining veterinary mentorship with a holistic approach to helping veterinary nurses/technicians thrive in every aspect of their career. MentorVet and the NAVC are partnering to offer an extension of the MentorVet Tech program to veterinary nurses and technicians with multiple flash mentorship sessions. These interactive 90-minute sessions will be provided for no additional cost during NAVC's HiVE Vet Nurse + Tech event October 16-18 in Austin, TX, and facilitated by the MentorVet Team.

Key Points: 
  • MentorVet and the NAVC are partnering to offer an extension of the MentorVet Tech program to veterinary nurses and technicians with multiple flash mentorship sessions.
  • "The NAVC is pleased to partner with MentorVet to help reach, recruit, and engage veterinary nurses and technicians to be part of this program," said NAVC CEO, Gene O'Neill.
  • "The NAVC is pleased to partner with MentorVet to help reach, recruit, and engage veterinary nurses and technicians to be part of this program," said NAVC CEO, Gene O'Neill.
  • MentorVet Tech was developed by Addie Reinhard, DVM, MS, mental health professionals, and expert veterinary technicians including MentorVet Tech program director, Alyssa Mages, BS, CVT.